Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
76 /100
CRITICAL RISK
Score updated Oct 13, 2026

PYXS — Pyxis Oncology, Inc. Dilution Risk Tracker

Track PYXS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PYXS — Get alerts when the score changes →

As of October 13, 2026, Pyxis Oncology, Inc. (PYXS) has a DilutionWatch DilutionScore of 76/100, rated CRITICAL dilution risk. Pyxis Oncology, Inc. has a market capitalization of $167.65M, 83.41M shares outstanding, 77 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
66
💰 Cash Runway
85
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 36%
🔄 Reverse Split model est. 45%
• 50-day avg $1.79 approaching $1 threshold
• Only 4 months cash — financial pressure
💰 Capital Raise model 35%
• Low cash runway: 4 months remaining
📉 Score Deterioration model 15%
• Score already CRITICAL (76/100) — events likely imminent
🔔 Track PYXS — Get forecast alerts →

Market Data

Market Cap$167.65M
Shares Outstanding83.41M
Float40.40M
Cash$33.00M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore76/100DilutionWatch score record
Shares Outstanding83.41MVerified float table or market cache
Public Float40.40MVerified float table or market cache
Market Cap$167.65MMarket data cache
Cash Runway4.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 12.4% shares (2026Q1 vs prior)
77 institutional holders · 31.46M shares
#1 Pfizer Inc 7.03M shares
#2 Laurion Capital Management LP 5.00M shares
#3 GordonMD Global Investments LP 4.12M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.89M
Days to Cover4.0
% of Float12.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2023-03-22
4 INSIDER TRANSACTION 2026-03-25
4 INSIDER TRANSACTION 2026-03-25
4 INSIDER TRANSACTION 2026-03-25
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PYXS Dilution Snapshot

Pyxis Oncology, Inc. (PYXS) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PYXS's DilutionScore is currently 76/100 (Critical risk), with 3 score changes tracked over 89 days. The score improved from 64/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202676/100CRITICAL13 days
Sep 17 – Sep 30, 202664/100HIGH14 days
Aug 22 – Sep 16, 202665/100HIGH26 days
Jul 16 – Aug 21, 202656/100HIGH36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PYXS shares outstanding have increased 0.8% from 62.83M (Mar 2026) to 63.36M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 202663.36M40.40M▼ 0.79%
May 23, 202663.36M40.72M▲ 0.26%
May 22, 202663.36M40.61M▼ 0.50%
May 16, 202663.36M40.81M▲ 1.02%
May 15, 202662.86M40.40M▲ 0.02%
Mar 27, 202662.83M40.40M▲ 0.51%
Mar 24, 202662.83M40.19M▲ 0.91%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PYXS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PYXS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PYXS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PYXS
PYXS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.